BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6152584)

  • 21. [Response to arrhythmic and antiarrhythmic agents of the automatic centers of different cardiac cavities].
    Faucon G; Evreux JC; Bazaugour R; Ollagnier M
    Therapie; 1971; 26(1):77-87. PubMed ID: 5102964
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacology of antiarrhythmia agents: the new aspects].
    Kaverina NV; Chichkanov GG
    Eksp Klin Farmakol; 2003; 66(2):46-52. PubMed ID: 12962048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-arrhythmia drug therapy from the pharmacologist's viewpoint].
    Méndez R
    Gac Med Mex; 1968 Jan; 98(1):13-22. PubMed ID: 4391214
    [No Abstract]   [Full Text] [Related]  

  • 24. Delayed repolarization as antiarrhythmic action.
    Olsson SB; Edvardsson N
    Eur Heart J; 1988 Feb; 9 Suppl B():37-43. PubMed ID: 3286265
    [No Abstract]   [Full Text] [Related]  

  • 25. New antiarrhythmic drugs.
    Flaker GC; Munuswamy K
    Am Fam Physician; 1982 Nov; 26(5):226-32. PubMed ID: 7148632
    [No Abstract]   [Full Text] [Related]  

  • 26. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 27. Rotigaptide (ZP123) reverts established atrial conduction velocity slowing.
    Haugan K; Kjølbye AL; Hennan JK; Petersen JS
    Cell Commun Adhes; 2005; 12(5-6):271-8. PubMed ID: 16531322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arrhythmias and heart failure].
    Amann FW; Candinas R
    Ther Umsch; 1993 Jun; 50(6):419-24. PubMed ID: 8351673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiarrhythmic action of certain 1,5-diphenyl-bispidin derivatives].
    Cartoni C; Figini A; Carpi A
    Ann Ist Super Sanita; 1968; 4(3):333-5. PubMed ID: 5734619
    [No Abstract]   [Full Text] [Related]  

  • 31. [Choice of cardiac antiarrhythmia agents].
    Kappenberger L; Biollaz J
    Ther Umsch; 1987 Aug; 44(8):591-5. PubMed ID: 3672412
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental and clinical pharmacology of cardiac arrhythmias.
    Haas HH
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):173-7. PubMed ID: 4254276
    [No Abstract]   [Full Text] [Related]  

  • 33. Quinidine like activity of a new central depressant 2-hydroxy-2-phenyl-ethyl carbamate (styramate).
    Singh KP
    Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):424-31. PubMed ID: 5868743
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 35. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of cardiac arrhythmias.
    Singer DH; Ten Eick RE
    Prog Cardiovasc Dis; 1969 May; 11(6):488-514. PubMed ID: 4892942
    [No Abstract]   [Full Text] [Related]  

  • 37. [The influence of antiarrhythmic drugs on parameters of signal-averaged electrocardiography].
    Banasiak W; Bobak J; Telichowski A
    Przegl Lek; 1997; 54(7-8):510-4. PubMed ID: 9480459
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of 5-hydroxytryptamine in atrial arrhythmias--an experimental study in dogs.
    Madan BR; Khanna NK; Godhwani JL; Pendse VK
    Indian J Physiol Pharmacol; 1969 Oct; 13(4):233-7. PubMed ID: 5382964
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of the restoration of vagal tone by intracisternal injection of dextromoramide on the cardiac effects of the antiarrhythmic drugs.
    Bertrix L; Bui-Xuan B; Lang J; Bouzouita K; Timour-Chah Q; Faucon G
    J Pharmacol; 1983; 14(3):361-72. PubMed ID: 6632916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs.
    Rensma PL; Allessie MA; Lammers WJ; Bonke FI; Schalij MJ
    Circ Res; 1988 Feb; 62(2):395-410. PubMed ID: 3338122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.